FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Blocker for Menopausal Hot Flashes

October 28, 2025

Roche to lay off 300 to 400 employees in product development jobs

July 5, 2021

Silence Therapeutics Halts Zerlasiran Phase 3 Despite 80% Lp(a) Reduction

February 28, 2025

Must Read

FDA Places Clinical Hold on Denali Therapeutics’ DNL952 for Pompe Disease

December 15, 2025

Breyanzi Receives FDA Approval for Marginal Zone Lymphoma

December 15, 2025

Wave Life Sciences Reports Interim Phase 1 Results for WVE-007 in Obesity Study

December 15, 2025

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

Breyanzi Receives FDA Approval for Marginal Zone Lymphoma

Wave Life Sciences Reports Interim Phase 1 Results for WVE-007 in Obesity Study

Bristol Myers Postpones Important Alzheimer’s Psychosis Cobenfy Readout

Belite Bio Succeeds in Rare Eye Disease Phase 3 Trial

Triana Biomedicines Secures $120 Million Series B to Advance Lead Molecular Glue Degrader

Crescent Boosts Pipeline with Kelun Deal Worth $80M

Regeneron and Tessera Partner to Advance TSRA-196 for Alpha-1 Antitrypsin Deficiency

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Reg impact assessment next in GenAI’s sights, experts claim

The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

Improving life science R&D outcomes with AI

The medical device sector’s surging regulatory burden: how are suppliers coping?

Brand & Marketing

UniQure sells hemophilia gene therapy royalty rights

Editor Picks

FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Blocker for Menopausal Hot Flashes

Roche to lay off 300 to 400 employees in product development jobs

Silence Therapeutics Halts Zerlasiran Phase 3 Despite 80% Lp(a) Reduction

Must Read

FDA Places Clinical Hold on Denali Therapeutics’ DNL952 for Pompe Disease

Breyanzi Receives FDA Approval for Marginal Zone Lymphoma

Wave Life Sciences Reports Interim Phase 1 Results for WVE-007 in Obesity Study

Hot Topics

About Us

Follow Us